{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:05:39Z","timestamp":1775246739130,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":1792,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"National Project of Infectious Diseases","award":["2017ZX10304402-003"],"award-info":[{"award-number":["2017ZX10304402-003"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"crossref","award":["2016YFC1202903"],"award-info":[{"award-number":["2016YFC1202903"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Plan for Scientific Research and Development of China","award":["2016YFD0500306"],"award-info":[{"award-number":["2016YFD0500306"]}]},{"name":"National Science and Technology Support Program","award":["2015BAI08B03"],"award-info":[{"award-number":["2015BAI08B03"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.micinf.2018.04.005","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T04:58:20Z","timestamp":1539147500000},"page":"56-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Identification of novel HLA-A11-restricted T-cell epitopes in the Ebola virus nucleoprotein"],"prefix":"10.1016","volume":"21","author":[{"given":"Dan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nianping","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunzhi","family":"Fa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huahu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchun","family":"Lone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2018.04.005_bib1","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1007\/PL00000821","article-title":"Ebola virus: the search for vaccines and treatments","volume":"58","author":"Wilson","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.micinf.2018.04.005_bib2","doi-asserted-by":"crossref","first-page":"e837","DOI":"10.1371\/journal.pntd.0000837","article-title":"Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis","volume":"4","author":"Wauquier","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.micinf.2018.04.005_bib3","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMoa1404505","article-title":"Emergence of zaire ebola virus disease in Guinea","volume":"371","author":"Baize","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2018.04.005_bib4","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJMoa1411100","article-title":"Ebola virus disease in West Africa\u2013the first 9 months of the epidemic and forward projections","volume":"371","author":"Aylward","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2018.04.005_bib5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1056\/NEJMsr1513109","article-title":"After Ebola in West Africa\u2013unpredictable risks, preventable epidemics","volume":"375","author":"Agua-Agum","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2018.04.005_bib6","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1128\/JVI.75.6.2660-2664.2001","article-title":"Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein","volume":"75","author":"Wilson","year":"2001","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2018.04.005_bib7","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1128\/JVI.76.18.9176-9185.2002","article-title":"Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells","volume":"76","author":"Rao","year":"2002","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2018.04.005_bib8","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4049\/jimmunol.175.2.1184","article-title":"Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection","volume":"175","author":"Warfield","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2018.04.005_bib9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature01876","article-title":"Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates","volume":"424","author":"Sullivan","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2018.04.005_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-2427(99)00039-2","article-title":"Duration of immunity, efficacy and safety in sheep of a recombinant Taenia ovis vaccine formulated with saponin or selected adjuvants","volume":"70","author":"Harrison","year":"1999","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.micinf.2018.04.005_bib11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s001090050270","article-title":"The influence of antigenic variation on cytotoxic T lymphocyte responses in HIV-1 infection","volume":"76","author":"Price","year":"1998","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.micinf.2018.04.005_bib12","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.4049\/jimmunol.163.5.2754","article-title":"Partial agonist effect influences the CTL response to a heterologous dengue virus serotype","volume":"163","author":"Zivny","year":"1999","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2018.04.005_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4137\/BBI.S13402","article-title":"A\u00a0computational assay to design an epitope-based Peptide vaccine against saint louis encephalitis virus","volume":"7","author":"Hasan","year":"2013","journal-title":"Bioinf Biol Insights"},{"key":"10.1016\/j.micinf.2018.04.005_bib14","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2147\/DDDT.S67861","article-title":"Design of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach","volume":"8","author":"Oany","year":"2014","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.micinf.2018.04.005_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.virol.2006.09.042","article-title":"Computational prediction and identification of HLA-A2.1-specific Ebola virus CTL epitopes","volume":"360","author":"Sundar","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2018.04.005_bib16","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nm.2447","article-title":"CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates","volume":"17","author":"Sullivan","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.micinf.2018.04.005_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.meegid.2015.10.012","article-title":"Computational elucidation of potential antigenic CTL epitopes in Ebola virus","volume":"36","author":"Dikhit","year":"2015","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.micinf.2018.04.005_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12864-017-4328-8","article-title":"Mapping HLA-A2, -A3 and -B7 supertype-restricted T-cell epitopes in the ebolavirus proteome","volume":"19","author":"Lim","year":"2018","journal-title":"BMC Genom"},{"key":"10.1016\/j.micinf.2018.04.005_bib19","doi-asserted-by":"crossref","first-page":"D405","DOI":"10.1093\/nar\/gku938","article-title":"The immune epitope database (IEDB) 3.0","volume":"43","author":"Vita","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.micinf.2018.04.005_bib20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1399-0039.1988.tb01656.x","article-title":"The polymorphism of HLA antigens in the Chinese","volume":"32","author":"Lee","year":"1988","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.micinf.2018.04.005_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s002510050594","article-title":"Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism","volume":"50","author":"Sette","year":"1999","journal-title":"Immunogenetics"},{"key":"10.1016\/j.micinf.2018.04.005_bib22","article-title":"High-resolution analyses of human leukocyte antigens allele and haplotype frequencies based on 169,995 volunteers from the China bone marrow donor registry program","volume":"10","author":"Zhou","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2018.04.005_bib23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/21645515.2015.1103405","article-title":"Generation of human MHC (HLA-A11\/DR1) transgenic mice for vaccine evaluation","volume":"12","author":"Zeng","year":"2016","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.micinf.2018.04.005_bib24","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.4049\/jimmunol.159.10.4753","article-title":"Derivation of HLA-A11\/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes","volume":"159","author":"Alexander","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2018.04.005_bib25","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1084\/jem.185.12.2043","article-title":"HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice","volume":"185","author":"Pascolo","year":"1997","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micinf.2018.04.005_bib26","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/intimm\/dxh129","article-title":"Comparison of HLA-DR1-restricted T cell response induced in HLA-DR1 transgenic mice deficient for murine MHC class II and HLA-DR1 transgenic mice expressing endogenous murine MHC class II molecules","volume":"16","author":"Pajot","year":"2004","journal-title":"Int Immunol"},{"key":"10.1016\/j.micinf.2018.04.005_bib27","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data","volume":"199","author":"Jurtz","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2018.04.005_bib28","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/bioinformatics\/btg108","article-title":"ProPred1: prediction of promiscuous MHC Class-I binding sites","volume":"19","author":"Singh","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/j.micinf.2018.04.005_bib29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs","volume":"50","author":"Rammensee","year":"1999","journal-title":"Immunogenetics"},{"key":"10.1016\/j.micinf.2018.04.005_bib30","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.vaccine.2010.10.037","article-title":"A\u00a0replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults","volume":"29","author":"Ledgerwood","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2018.04.005_bib31","doi-asserted-by":"crossref","first-page":"7613","DOI":"10.1016\/j.vaccine.2010.09.055","article-title":"Mucosal adenovirus-vectored vaccine for measles","volume":"28","author":"Lobanova","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2018.04.005_bib32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00109-010-0696-0","article-title":"Development of adenoviral vector-based mucosal vaccine against influenza","volume":"89","author":"Tutykhina","year":"2011","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.micinf.2018.04.005_bib33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/35046108","article-title":"Development of a preventive vaccine for Ebola virus infection in primates","volume":"408","author":"Sullivan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2018.04.005_bib34","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1371\/journal.pmed.0030177","article-title":"Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs","volume":"3","author":"Sullivan","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.micinf.2018.04.005_bib35","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2018.04.005_bib36","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/S0140-6736(15)60553-0","article-title":"Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial","volume":"385","author":"Zhu","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2018.04.005_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1473-3099(15)00362-X","volume":"16","author":"Tapia","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.micinf.2018.04.005_bib38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2018.04.005_bib39","doi-asserted-by":"crossref","first-page":"e1275","DOI":"10.1371\/journal.pntd.0001275","article-title":"A\u00a0replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus","volume":"5","author":"Tsuda","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.micinf.2018.04.005_bib40","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1080\/21645515.2017.1329788","article-title":"An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice","volume":"13","author":"Bounds","year":"2017","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.micinf.2018.04.005_bib41","doi-asserted-by":"crossref","first-page":"14189","DOI":"10.1128\/JVI.79.22.14189-14196.2005","article-title":"Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins","volume":"79","author":"Olinger","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2018.04.005_bib42","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.virol.2003.09.016","article-title":"Identification of murine T-cell epitopes in Ebola virus nucleoprotein","volume":"318","author":"Simmons","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2018.04.005_bib43","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1034\/j.1399-0039.2001.057003192.x","article-title":"The origin of Minnan and Hakka, the so-called \u201cTaiwanese\u201d, inferred by HLA study","volume":"57","author":"Lin","year":"2001","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.micinf.2018.04.005_bib44","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1002\/eji.200425463","article-title":"A\u00a0mouse model of human adaptive immune functions: HLA-A2.1-\/HLA-DR1-transgenic H-2 class I-\/class II-knockout mice","volume":"34","author":"Pajot","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.micinf.2018.04.005_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032247","article-title":"Development of a humanized HLA-A2.1\/DP4 transgenic mouse model and the use of this model to map HLA-DP4-restricted epitopes of HBV envelope protein","volume":"7","author":"Ru","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2018.04.005_bib46","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1046-2023(02)00348-1","article-title":"T-cell epitope mapping using the ELISPOT approach","volume":"29","author":"Anthony","year":"2003","journal-title":"Methods"},{"key":"10.1016\/j.micinf.2018.04.005_bib47","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2174\/156652407780831584","article-title":"Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice","volume":"7","author":"McMurry","year":"2007","journal-title":"Curr Mol Med"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457918300972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457918300972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:16:14Z","timestamp":1775243774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457918300972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1286457918300972"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2018.04.005","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of novel HLA-A11-restricted T-cell epitopes in the Ebola virus nucleoprotein","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2018.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS on behalf of Institut Pasteur.","name":"copyright","label":"Copyright"}]}}